基于七氟烷的多模式镇静联合目标温度管理降低心脏骤停后患者谵妄发生率:一项观察性倾向评分匹配研究
该回顾性倾向评分匹配研究比较了院外心脏骤停(OHCA)后入住ICU患者两种镇静与目标温度管理方案:七氟烷镇静联合改良目标温度管理(34-36℃,mTTM-36/sevo组)与静脉镇静联合经典目标温度管理(32-34℃,TTM-33/IV组)。主要结果为mTTM-36/sevo组谵妄发生率显著更低(16.1% vs 37.3%,p=0.001),机械通气时间、ICU住院时间和总住院时间更短,静脉镇静组需更多咪达唑仑、丙泊酚和芬太尼,两组死亡率无显著差异。
要点
- OHCA后ICU患者使用七氟烷镇静联合34-36℃目标温度管理,谵妄发生率16.1%(9/56),低于静脉镇静联合32-34℃组的37.3%(25/67),p=0.001。
- 七氟烷联合34-36℃组机械通气时间和ICU住院时间均显著缩短(p<0.001),医院住院时间亦缩短(p=0.04)。
- 静脉镇静联合32-34℃组需要更多咪达唑仑、丙泊酚和芬太尼。
- 两组死亡率无显著差异。
- 该研究为回顾性观察性倾向评分匹配设计,结论需前瞻性验证。
适用人群与场景
- 院外心脏骤停(OHCA)后入住ICU并接受目标温度管理和镇静治疗的患者。
诊断标准与关键阈值
- 谵妄评估采用ICU意识模糊评估法(confusion assessment method for the ICU)。
- 目标温度管理分组:TTM-33/IV组目标温度32-34℃;mTTM-36/sevo组目标温度34-36℃。
处置流程与药物剂量
- mTTM-36/sevo组:采用基于七氟烷的多模式镇静方案,联合目标温度管理34-36℃。
- TTM-33/IV组:采用静脉镇静(原文提及使用咪达唑仑、丙泊酚和芬太尼),联合目标温度管理32-34℃。
- 原文未提及七氟烷的具体剂量、给药途径细节、咪达唑仑/丙泊酚/芬太尼的具体剂量及疗程。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性观察性倾向评分匹配研究。
- 样本量与中心数:原文未提及总样本量及中心数;匹配后mTTM-36/sevo组56例,TTM-33/IV组67例。
- 人群:OHCA后入住ICU患者。
- 干预与对照:七氟烷多模式镇静联合34-36℃目标温度管理(mTTM-36/sevo) vs 静脉镇静联合32-34℃目标温度管理(TTM-33/IV)。
- 主要终点:谵妄发生率mTTM-36/sevo组16.1%(9/56) vs TTM-33/IV组37.3%(25/67),p=0.001。
- 关键次要终点:机械通气时间和ICU住院时间在mTTM-36/sevo组更短(p<0.001),医院住院时间更短(p=0.04);TTM-33/IV组需要更多咪达唑仑、丙泊酚和芬太尼;两组死亡率无显著差异。
证据类型、等级与局限
- 证据类型:回顾性观察性研究,采用倾向评分匹配分析。
- 证据等级或推荐强度:原文未提及。
对床旁实践的改变
- 对于OHCA后接受目标温度管理的ICU患者,基于七氟烷的多模式镇静联合34-36℃目标温度管理可能降低谵妄发生率、缩短机械通气时间和ICU住院时间。
- 该方案可能减少静脉镇静药(咪达唑仑、丙泊酚、芬太尼)的需求量。
- 适用人群为OHCA后入住ICU的患者;不适用于原文未提及的人群。
- 常见陷阱:该研究为回顾性观察性设计,不能据此推断因果关系;七氟烷的具体使用方案(剂量、给药方式)原文未详细描述,临床实施需参考本机构条件和相关指南。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Recent studies suggest that volatile anaesthetics are safe, efficient, and reliable alternatives to the use of intravenous anaesthetics for out-of-hospital cardiac arrest (OHCA) patients admitted to the intensive care unit (ICU). We hypothesised that volatile anaesthetics may reduce the incidence of delirium rather than intravenous sedatives. This retrospective study aimed to investigate whether sevoflurane combined with higher targeted temperature management could decrease the incidence of delirium when compared with intravenous anaesthetics with lower targeted temperature management.
METHODS: Using a propensity score-matched analysis, we retrospectively compared a target temperature management (32-34 °C) method along with intravenous sedation (TTM-33/IV) and a modified target temperature management (34-36 °C) method along with sevoflurane sedation (mTTM-36/sevo). We used the confusion assessment method for the ICU to measure the incidence of delirium. We calculated the time-dependent risk on delirium using the multivariate Cox regression model.
RESULTS: The incidence of delirium was significantly lower (p = 0.001) in OHCA patients of the mTTM-36/sevo group (9/56, 16.1%) than in those of the TTM-33/IV group (25/67, 37.3%). Mechanical ventilation and lengths of stay in the ICU (p < 0.001) and hospital stay (p = 0.04) were shorter in the mTTM-36/sevo group. Patients in the TTM-33/IV group required more midazolam, propofol, and fentanyl. We observed no significant difference in mortality.
CONCLUSION: A multimodal sevoflurane-based sedation regimen together with targeted temperature management resulted in a lower incidence of delirium and a shorter duration for mechanical ventilation and ICU length of stay than did the treatment with intravenous sedation combined with the classical cooling protocol.
参考来源
- Foudraine NA, Algargoush A, van Osch FH, et al. A multimodal sevoflurane-based sedation regimen in combination with targeted temperature management in post-cardiac arrest patients reduces the incidence of delirium: An observational propensity score-matched study. Resuscitation. 2020. PMID: 33189803. doi:10.1016/j.resuscitation.2020.10.042
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。